Status:
COMPLETED
The Role of TextRAd on Detection of Liver Metastasis in Rectal Cancer
Lead Sponsor:
East Suffolk and North Essex NHS Foundation Trust
Conditions:
Rectal Cancer
Eligibility:
All Genders
Brief Summary
This is a retrospective analysis of all patients diagnosed with LARC who received NCRT and had MRI scans between 2003-2014 at East Suffolk and North Essex NHS Foundation Trust. Region of interest was ...
Eligibility Criteria
Inclusion
- All subjects must have MRI post-Chemotherapy treatment to detect the response to Neoadjuvant treatment and compare it to pre-treatment scans to easily determine if there were a posttreatment liver metastasis.
- Locally advanced rectal cancer (LARC) = MRI stage: T3/T4 and/or N1/N0.
Exclusion
- Distant metastases.
- Synchronous tumour.
Key Trial Info
Start Date :
July 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 18 2021
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT05398822
Start Date
July 18 2019
End Date
July 18 2021
Last Update
June 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
East Suffolk and North Essex NHS Foundation Trust
Ipswich, United Kingdom, IP4 5PD